NovaBay Pharmaceuticals Inc (NBY) USD0.01

Sell:$0.77Buy:$0.78Price increased$0.01 (1.10%)

Prices delayed by at least 15 minutes
Sell:$0.77
Buy:$0.78
Change:Price increased$0.01 (1.10%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.77
Buy:$0.78
Change:Price increased$0.01 (1.10%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

Key people

Michael Kazley
Chairman of the Board, Chief Executive Officer
Tommy Law
Chief Financial Officer, Treasurer
Justin M. Hall
Vice President - Business Development, General Counsel, Corporate Secretary
Paul E. Freiman
Director
Swan Sit
Independent Director
Yenyou Zheng
Independent Director
Click to see more

Key facts

  • Shares in issue
    126.17m
  • EPIC
    NBY
  • ISIN
    US66987P4090
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $119.87m
  • Employees
    14
  • Exchange
    Nyse American LLC
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.